NASDAQ:MYO - Myomo Stock Price, News, & Analysis

$0.87
+0.06 (+7.41 %)
(As of 06/20/2019 04:00 PM ET)
Today's Range
$0.85
Now: $0.87
$0.87
50-Day Range
$0.76
MA: $0.98
$1.29
52-Week Range
$0.74
Now: $0.87
$3.12
Volume3,866 shs
Average Volume91,726 shs
Market Capitalization$14.87 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Myomo, Inc., a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro, a powered upper limb orthosis that supports the arm, as well as restores function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, ALS, or other neuromuscular disease or injury. The company serves orthotics and prosthetics practices or clinics, as well as the veteran administration and other hospitals through orthotics and prosthetics providers, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MYO
CUSIPN/A
CIKN/A
Phone617-996-9058

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$14.87 million
Next Earnings Date8/6/2019 (Estimated)
OptionableNot Optionable

Receive MYO News and Ratings via Email

Sign-up to receive the latest news and ratings for MYO and its competitors with MarketBeat's FREE daily newsletter.

Myomo (NASDAQ:MYO) Frequently Asked Questions

What is Myomo's stock symbol?

Myomo trades on the NASDAQ under the ticker symbol "MYO."

When is Myomo's next earnings date?

Myomo is scheduled to release their next quarterly earnings announcement on Tuesday, August 6th 2019. View Earnings Estimates for Myomo.

What is the consensus analysts' recommendation for Myomo?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Myomo in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Myomo.

Has Myomo been receiving favorable news coverage?

Media coverage about MYO stock has been trending somewhat negative on Thursday, InfoTrie Sentiment reports. The research group identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Myomo earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 9.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the immediate future. View News Stories for Myomo.

Who are some of Myomo's key competitors?

Who are Myomo's key executives?

Myomo's management team includes the folowing people:
  • Mr. Paul R. Gudonis, Chairman, Pres & CEO (Age 63)
  • Ms. Davie Mendelsohn RN, VP of Sales & Clinical Services (Age 64)
  • Mr. Jonathan Naft, VP & GM (Age 53)
  • Mr. Ralph A. Goldwasser, Chief Financial Officer (Age 70)
  • Mr. Clifford J. Conneighton, Chief Marketing Officer (Age 68)

How do I buy shares of Myomo?

Shares of MYO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Myomo's stock price today?

One share of MYO stock can currently be purchased for approximately $0.87.

How big of a company is Myomo?

Myomo has a market capitalization of $14.87 million. View Additional Information About Myomo.

What is Myomo's official website?

The official website for Myomo is http://www.myomo.com/.

How can I contact Myomo?

The company can be reached via phone at 617-996-9058.


MarketBeat Community Rating for Myomo (NASDAQ MYO)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  30 (Vote Outperform)
Underperform Votes:  33 (Vote Underperform)
Total Votes:  63
MarketBeat's community ratings are surveys of what our community members think about Myomo and other stocks. Vote "Outperform" if you believe MYO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MYO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel